|
HMGXB4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.235000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.134440E-02 |
| Normal-vs-Stage2 |
6.045000E-04 |
| Normal-vs-Stage3 |
6.198600E-03 |
| Normal-vs-Stage4 |
2.225800E-02 |
| Stage1-vs-Stage2 |
6.096400E-02 |
| Stage1-vs-Stage3 |
5.501800E-01 |
| Stage1-vs-Stage4 |
8.423800E-01 |
| Stage2-vs-Stage3 |
1.985580E-01 |
| Stage2-vs-Stage4 |
1.824210E-01 |
| Stage3-vs-Stage4 |
8.140800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.480300E-03 |
| Normal-vs-AfricanAmerican |
1.975200E-01 |
| Normal-vs-Asian |
8.766200E-02 |
| Caucasian-vs-AfricanAmerican |
6.792200E-01 |
| Caucasian-vs-Asian |
7.620000E-01 |
| AfricanAmerican-vs-Asian |
8.831600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.171700E-04 |
| Normal-vs-Female |
8.600300E-03 |
| Male-vs-Female |
2.100800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.262000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.455310E-03 |
| Normal-vs-Age(61-80Yrs) |
6.448800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.511030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.495020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.659800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.401800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.137200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.030600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.153800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.678800E-01 |
| Classical-VS-Follicular |
1.45989997868412E-09 |
| Classical-VS-Other |
9.007700E-02 |
| Classical-VS-Normal |
9.084300E-02 |
| Tall-VS-Follicular |
1.8059299999984E-05 |
| Tall-VS-Other |
5.295800E-02 |
| Tall-VS-Normal |
6.928400E-01 |
| Follicular-VS-Other |
7.712400E-01 |
| Follicular-VS-Normal |
1.37219999807314E-08 |
| Other-VS-Normal |
2.129700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.389760E-04 |
| Normal-vs-N1 |
6.061900E-02 |
| N0-vs-N1 |
1.384360E-01 |
|
|
